The investigational oral therapy is a new chemical entity designed to reduce the dimerization of vitamin A without modulating the visual cycle, according to Alkeus Pharmaceuticals. #StargardtDisease #Ophthalmology Pipeline details and available clinical data: https://lnkd.in/eYpGzXvD
关于我们
Office- and hospital-based pediatricians and nurse practitioners use Contemporary Pediatrics' timely, trusted, and practical information to enhance their day-to-day care of children. We advance pediatric providers' professional development through in-depth, peer-reviewed clinical and practice management articles, case studies, and news and trends coverage.
- 网站
-
https://www.contemporarypediatrics.com
Contemporary Pediatrics的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 51-200 人
- 总部
- Cranbury ，New Jersey
- 类型
- 私人持股
- 领域
- Pediatrics、Healthcare、Digital Media、Print Media、Editorial和Content Marketing
地点
-
主要
获取路线
2 Clarke Dr
Suite 100
US，New Jersey，Cranbury ，08512
Contemporary Pediatrics员工
-
Andrew Schuman
Member, Editorial Advisory Board at Contemporary Pediatrics
-
Cassandra Pfeiffer
Front Office Specialist Contemporary Pediatrics
-
Charmaine Yuan
Resident physician in the Johns Hopkins Harriet Lane Pediatric Residency Program
-
Joshua Fitch
Senior Editor for Contemporary Pediatrics - MJH Life Sciences
动态
-
Understanding the increase of risk related to new diagnosis of #T2D, "will add an important component to consideration of the risks and benefits of preventing SARS-CoV-2 infection in children," wrote the study authors. #Diabetes #obesity Recent study data here: https://lnkd.in/esgUj6RK
COVID-19 among adolescents, teens and type 2 diabetes incidence
contemporarypediatrics.com
-
According to a new Morbidity and Mortality Weekly Report ( MMWR ) from the Centers for Disease Control and Prevention, #antiviral treatment for hospitalized #influenza pediatric patients has declined. From 2017-2018, antiviral treatment of hospitalized children with influenza ranged from 70%-86%. In the 2023-2024 season, it was less than 60%. Full details: https://lnkd.in/gQP9pXjT
Antiviral treatment for hospitalized influenza pediatric patients declining
contemporarypediatrics.com
-
In this video discussion, David Turkewitz, MD, medical director of Newborn Nurseries at Allegheny Health Network, offers clinical pearls to reduce the risk of #SIDS and reviews the updated 2022 guidelines from the American Academy of Pediatrics. Watch: https://lnkd.in/ewAii--b
Reviewing the AAP's sudden infant death syndrome 2022 guidelines
contemporarypediatrics.com
-
If you missed it: The #FDA has approved Kebilidi to treat aromatic L-amino acid decarboxylase deficiency. With the decision, Kebilidi becomes the first FDA-approved gene therapy for #AADC deficiency, and is indicated for adult and #pediatric patients. More: https://lnkd.in/gSAxzDPG
FDA approves Kebilidi as first gene therapy to treat aromatic L-amino acid decarboxylase deficiency
contemporarypediatrics.com
-
Reportedly, the child experienced mild symptoms and has received flu antivirals. This confirmation marks the first reported avian influenza H5 virus infection among a child in the United States, according to the CDC. Details: https://lnkd.in/gKG-a2vc
CDC confirms H5N1 bird flu infection in California child
contemporarypediatrics.com
-
Reportedly, the child experienced mild symptoms and has received flu antivirals. This confirmation marks the first reported avian influenza H5 virus infection among a child in the United States, according to the CDC. Details: https://lnkd.in/gKG-a2vc
CDC confirms H5N1 bird flu infection in California child
contemporarypediatrics.com
-
If you missed it: New #Phase2 data for investigational infigratinib ( BridgeBio Pharma ) in children with #achondroplasia was announced earlier this week. View key datapoints below, and click for full study results. Click here for a full data breakdown and expert commentary: https://lnkd.in/eJ3E7TVC
-
-
The investigational oral therapy is a new chemical entity designed to reduce the dimerization of vitamin A without modulating the visual cycle, according to Alkeus Pharmaceuticals. #StargardtDisease #Ophthalmology Pipeline details and available clinical data: https://lnkd.in/eYpGzXvD
Gildeuretinol for Stargardt disease receives Rare Pediatric Disease, Fast Track Designations
contemporarypediatrics.com
-
In this video discussion, David Turkewitz, MD, medical director of Newborn Nurseries at Allegheny Health Network, offers clinical pearls to reduce the risk of #SIDS and reviews the updated 2022 guidelines from the American Academy of Pediatrics. Watch: https://lnkd.in/ewAii--b
Reviewing the AAP's sudden infant death syndrome 2022 guidelines
contemporarypediatrics.com